NALLI, CECILIA
 Distribuzione geografica
Continente #
NA - Nord America 817
EU - Europa 479
AS - Asia 260
AF - Africa 2
OC - Oceania 1
Totale 1.559
Nazione #
US - Stati Uniti d'America 815
PL - Polonia 98
SG - Singapore 90
IT - Italia 79
CN - Cina 78
DE - Germania 78
UA - Ucraina 53
HK - Hong Kong 49
FI - Finlandia 47
TR - Turchia 28
GB - Regno Unito 27
IE - Irlanda 26
RU - Federazione Russa 25
FR - Francia 14
SE - Svezia 8
MK - Macedonia 7
GR - Grecia 4
VN - Vietnam 4
BE - Belgio 2
CH - Svizzera 2
ES - Italia 2
IN - India 2
PH - Filippine 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
CA - Canada 1
CZ - Repubblica Ceca 1
ID - Indonesia 1
IQ - Iraq 1
JM - Giamaica 1
JP - Giappone 1
KZ - Kazakistan 1
NL - Olanda 1
NZ - Nuova Zelanda 1
RS - Serbia 1
UG - Uganda 1
ZA - Sudafrica 1
Totale 1.559
Città #
Fairfield 122
Warsaw 98
Singapore 78
Woodbridge 69
Ashburn 61
Houston 59
Seattle 50
Hong Kong 48
Helsinki 46
Jacksonville 45
Cambridge 44
Princeton 44
New York 42
Chandler 37
Wilmington 36
Ann Arbor 27
Istanbul 27
Dublin 26
Beijing 17
Brescia 16
Shanghai 16
Munich 15
Nanjing 10
Lancaster 9
Moscow 9
Des Moines 8
Los Angeles 7
Rome 7
San Diego 7
Hebei 6
Milan 6
Romola 5
Bosio 4
Dong Ket 4
Nanchang 4
Changsha 3
Duncan 3
London 3
Skopje 3
Strasbourg 3
Bagheria 2
Brussels 2
Chengdu 2
Cosenza 2
Crotone 2
Frankfurt am Main 2
Hangzhou 2
Jiaxing 2
Khobar 2
Lanzhou 2
Manerbio 2
Motta Baluffi 2
Redwood City 2
San Francisco 2
Santa Cruz de Tenerife 2
Tianjin 2
Acton 1
Almaty 1
Amsterdam 1
Aosta 1
Auckland 1
Augusta 1
Belgrade 1
Brno 1
Cagayan de Oro 1
Centurion 1
Changchun 1
Clearwater 1
Gunzenhausen 1
Islington 1
Jakarta 1
Jinan 1
Kilburn 1
Levice 1
Magdeburg 1
Mountain View 1
New Bedfont 1
Norwalk 1
Nürnberg 1
Redmond 1
Rivoli 1
Shenyang 1
Soncino 1
Taiyuan 1
Taizhou 1
Tangshan 1
Tokyo 1
Toronto 1
Tower Hamlets 1
Washington 1
Westminster 1
Zhengzhou 1
Zurich 1
Totale 1.193
Nome #
Long-term outcome of children of rheumatic disease patients 175
Antirheumatic drugs and reproduction in women and men with chronic arthritis. 156
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 114
Long-term neurodevelopmental outcome of children born to prospectively followed pregnancies of women with systemic lupus erythematosus and/or antiphospholipid syndrome 109
Anti-phospholipid IgG antibodies detected by line immunoassay differentiate patients with anti-phospholipid syndrome and other autoimmune diseases 98
Long-term outcome of children born from mothers with autoimmune diseases 94
Recurrent thrombosis in patients with antiphospholipid antibodies and arterial thrombosis on antithrombotic therapy 85
Beyond thrombosis: Anti-β2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome 60
“Disease knowledge index” and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseases 59
Disease course and obstetric outcomes of pregnancies in juvenile idiopathic arthritis: are there any differences among disease subtypes? A single-centre retrospective study of prospectively followed pregnancies in a dedicated pregnancy clinic 57
Autoimmune diseases and pregnancy 56
Infertility in women with systemic autoimmune diseases 54
Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study 48
Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): Report of 1640 cases from the EUROAPS registry 41
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals 41
“APS pregnancy – The offspring” 40
CXCL-13 serum levels in patients with rheumatoid arthritis treated with abatacept 40
Managing puerperium in patients with systemic autoimmune diseases: an update 37
The Influence of Treatment of Inflammatory Arthritis During Pregnancy on the Long-Term Children's Outcome. 36
Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies. 36
Gender differences in primary antiphospholipid syndrome with vascular manifestations in 433 patients from four European centres 33
Clinical Delphi on aPLnegativization: report from the from the APS Study Group of the Italian Society for Rheumatology (SIR-APS) 28
Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis 26
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 20
Pregnancy in antiphospholipid syndrome: what should a rheumatologist know? 16
Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study 11
The prevalence and incidence of thrombotic primary antiphospholipid syndrome in adults aged 18-49 years: A population-based study in a mountain community in northern Italy 11
Erratum: Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS) 8
Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry 7
Reproductive Health in Scleroderma, Vasculitis, and Sjögren Syndrome 5
Totale 1.601
Categoria #
all - tutte 11.702
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.702


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020152 0 0 0 0 0 27 23 25 22 20 22 13
2020/2021302 4 30 15 28 30 24 39 20 31 37 28 16
2021/2022211 18 37 11 10 1 14 7 13 11 22 24 43
2022/2023158 31 0 3 2 19 44 0 11 22 1 13 12
2023/2024268 18 12 27 28 9 55 10 16 49 12 3 29
2024/2025229 18 11 10 79 54 57 0 0 0 0 0 0
Totale 1.601